Kintara Therapeutics Inc
KTRA
NSC
Sector: Manufacturing
Industry: Polish and Other Sanitation Good Manufacturing
0.34
USD
-0.01
(-2.48%)
Optionable: No Market Cap: 1 M 90-day average vol: 425,934
Previous close: 0.3504 Open: 0.3521 Bid: 0.3379 Ask: 0.36
52 week range
0.32 15.50
Last updated: Tuesday 28th November 2023
Get Access to 1 Billion Usable Market data points IN YOUR EXCEL SHEETS WITH EASY TO USE EXCEL FUNCTIONS
Get started todaySearch for a stock
🎉 Exciting news! 🎉
You are invited to join our Discord Channel.
Interact, learn, and grow with experts in the markets!
Join our DiscordFinancials
KTRA Income Statement
Annual
| Jun-12 | Dec-13 | Jun-15 | Jun-16 | Jun-17 | Jun-18 | Jun-19 | Jun-20 | Jun-21 | Jun-22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| AccruedPreferredStockDividends | -238326.0 | -790454.0 | -176236.0 | 80431.0 | 17000.0 | 3 M | 2 M | |||
| Amortization | -10288.0 | -16683.0 | -24528.0 | -16349.0 | -10000.0 | 94000.0 | ||||
| Basic EPS from continuing operations | 43.5 | -80.0 | -0.52 | |||||||
| Basic EPS total | 6.5 | 40.5 | 37.0 | 27.0 | 158.0 | 43.5 | -80.0 | -0.52 | ||
| Basic weighted shares outstanding | 3 M | 30 M | 761350.0 | 218969.0 | 240941.0 | 417228.0 | 51493.0 | 208880.0 | 517720.0 | 49 M |
| Depreciation unreconciled | 94000.0 | |||||||||
| DepreciationAndAmortization | 94000.0 | |||||||||
| Diluted EPS total | -0.28 | 6.5 | 43.5 | -80.0 | -0.52 | |||||
| Diluted weighted shares outstanding | 30 M | 761350.0 | 218885.0 | 231547.0 | 412530.0 | 50938.0 | 208880.0 | 517720.0 | 49 M | |
| GainOnSaleOfSecurity | 1 M | 627433.0 | 2 M | -245963.0 | -60111.0 | -433503.0 | ||||
| GeneralAndAdministrativeExpense | 18885.0 | 4 M | 2 M | 3 M | -3 M | -4 M | 5 M | 5 M | 10 M | 8 M |
| ImpairmentOfCapitalAssets | 23658.0 | |||||||||
| Income before tax | -18885.0 | -8 M | -4 M | -4 M | 8 M | 11 M | -9 M | -9 M | -38 M | -23 M |
| Income taxes | 305647.0 | 4783.0 | -34116.0 | 62962.0 | -138516.0 | -106320.0 | -322689.0 | -196000.0 | ||
| Interest income | 2491.0 | -225041.0 | -295348.0 | 126186.0 | ||||||
| InterestExpenseNonOperating | 8020.0 | 2091.0 | -30000.0 | |||||||
| LossAndLossAdjustmentExpectedIncurred | -124020.0 | -677445.0 | -81602.0 | -192400.0 | -23715.0 | -287000.0 | -569000.0 | |||
| MarketingExpense | -295456.0 | |||||||||
| MiscOtherSpecialCharges | -3 M | 2 M | -331057.0 | -60111.0 | 925270.0 | |||||
| Net income from total operations | -37770.0 | -8 M | -4 M | -4 M | 8 M | 11 M | -9 M | -9 M | -38 M | -23 M |
| NetIncomeCommonStockholders | -37770.0 | -8 M | -4 M | -3 M | 9 M | 11 M | -9 M | -9 M | -42 M | -25 M |
| NetIncomeContinuousOperations | -37770.0 | -8 M | -4 M | -4 M | 8 M | 11 M | -9 M | -9 M | -38 M | -23 M |
| NetIncomeExtraordinary | -18885.0 | |||||||||
| NetNonOperatingInterestIncomeExpense | -5529.0 | -227132.0 | -295348.0 | 126186.0 | 30000.0 | |||||
| NonRecurringOperationExpense | -1 M | -500000.0 | -2 M | |||||||
| Operating income | -18885.0 | -6 M | -5 M | -6 M | 8 M | 11 M | -8 M | -9 M | -38 M | -23 M |
| Operating income before depreciation (EBITDA) | -18885.0 | -8 M | -4 M | -4 M | 8 M | 11 M | -9 M | -9 M | -38 M | -23 M |
| OperatingExpense | -18885.0 | -6 M | -5 M | -6 M | 8 M | 11 M | -8 M | 9 M | 38 M | 23 M |
| Other income net | 2 M | -627433.0 | -2 M | 245963.0 | 60111.0 | 433503.0 | -17 M | -17 M | ||
| OtherGandA | 18885.0 | 4 M | 2 M | 3 M | -3 M | -4 M | 5 M | 5 M | 10 M | 8 M |
| OtherOperatingExpenses | 108.0 | 457.0 | 33243.0 | -60704.0 | 979000.0 | 17 M | -14000.0 | |||
| OtherTaxes | -127100.0 | -207080.0 | ||||||||
| OtherunderPreferredStockDividend | -6267.0 | -238326.0 | -790454.0 | -176236.0 | 80431.0 | 17000.0 | 3 M | 2 M | ||
| PreferredStockDividends | -6267.0 | -238326.0 | -790454.0 | -176236.0 | 80431.0 | 17000.0 | 3 M | 2 M | ||
| RealizedCapitalGain | 249062.0 | |||||||||
| RentAndLandingFees | 4 M | 2 M | 3 M | -3 M | -4 M | 5 M | -40000.0 | -40000.0 | -8 M | |
| Research & development expense | 2 M | 3 M | 3 M | -5 M | -7 M | 4 M | 4 M | 12 M | 15 M | |
| ResearchExpense | 2 M | 3 M | 3 M | -5 M | -7 M | 4 M | 4 M | 12 M | 15 M | |
| SalariesAndWages | -2 M | -186900.0 | -295456.0 | -124747.0 | -495925.0 | -426029.0 | -495000.0 | -5 M | -2 M | |
| Selling Gen & administrative expense | 18885.0 | 4 M | 2 M | 3 M | -3 M | -4 M | 5 M | 5 M | 10 M | 8 M |
| SellingAndMarketingExpense | -295456.0 | |||||||||
| Special income/charges | -23658.0 | 1 M | 500000.0 | 2 M | ||||||
| Total Income available for interest expense (EBIT) | -18885.0 | -8 M | -4 M | -4 M | 8 M | 11 M | -9 M | -9 M | -38 M | -23 M |
| Total common shares outstanding | 6 M | 24 M | 19738.0 | 20634.0 | 43103.0 | 44818.0 | 227769.0 | 470877.0 | 863499.0 | 81 M |
| Total net income | -37770.0 | -8 M | -4 M | -4 M | 8 M | 11 M | -9 M | -9 M | -38 M | -23 M |
| Total ordinary shares | 2 M | 2 M | 2 M | 2 M | 2 M | 2 M | 2 M | 2 M | 2 M | 2 M |
| TotalExpenses | -18885.0 | -6 M | -5 M | -6 M | 8 M | 11 M | -8 M | 9 M | 38 M | 23 M |
Call: 1-877-778-8358
Welcome! I'm Ankur, the founder/CEO of MarketXLS. With over six years of experience, I've helped 2500+ customers implement personalized investment research strategies and monitoring systems in Excel.
Implement “your own” investment strategies in Excel with thousands of MarketXLS functions and templates.
Get started today
Get started today